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Aussi disponible en français sous le titre de :
Enquête sur les aliments fonctionnels et les nutraceutiques – Résumé3
This report provides an overview of the Functional Food and Nutraceuticals (FFN) 
survey.  The FFN survey was conducted by Statistics Canada on behalf of 
Agriculture and Agri-Food Canada.  The objective of the survey was to produce 
new statistical information on the functional food and nutraceutical sector and a 
profile of firms engaged in functional and/or nutraceutical-related activities in 
Canada.  The information obtained will be useful to government departments and 
agencies to assist policy development and to the academic community for research 
purposes. The information may also be used by businesses and trade associations 
for economic, market or industry performance analyses.
This report is meant to describe the FNN industry and to establish baseline 
indicators and measurements.
It begins with a look at the structure of the Canadian FFN industry, then reviews the 
labour and capital inputs, the business relationships and intellectual property rights 
and ends with the impact of regulations in the Canadian FNN industry. Charts, 
figures and tables with brief accompanying texts are used to summarize the 
information and to provide baseline structure/performance indicators. 
The report reveals that  firms in the Canadian FNN industry are mostly made up of 
small Canadian controlled firms, with more firms engaged in nutraceutical activities 
than functional foods. Almost 90 percent of responding firms were engaged in 
partnerships or seeking partnerships.  Trade secrets seem to be the most commonly 
used method to protect intellectual property.  In general, most firms in the industry 
felt that the ability to use health claims on their FFN products would have a positive 
impact on both domestic and export sales.  
Foreword45
• Survey purpose:
To produce first-ever information on companies in the Canadian functional food and 
nutraceutical (FFN) industry.
• Respondents: 
Senior managers of the companies involved in FFN activities.
• Sample size:
Approximately 600 companies across Canada.
• Number of total respondents:
276 respondents, which is a 48% overall response rate.
• Number of respondents qualifying as FFN industry participants:
147 respondents, which is 53% of the total number of respondents.
• Collection period:
Spring 2003.
Functional Foods and Nutraceuticals Survey 
Description6
Functional foods: are similar in appearance to, or are conventional foods 
demonstrated to have physiological benefits and/or reduce the risk of chronic 
disease beyond basic nutritional functions. 
Functional foods may be developed by adding active ingredients to basic food 
products (e.g., muffins with beta-glucan, foods with added soluble fibre, etc.) or by 
using  special production techniques such as plant breeding, genetic modification 
and specialized feeding regimes (e.g., tomatoes with enhanced lycopene levels, 
omega-3 eggs, etc.)
Nutraceuticals: are products purified from foods that are generally sold in 
medicinal forms,  such as powders, tablets or capsules, demonstrated to have 
physiological benefits or to provide protection against chronic disease. 
Nutraceuticals can be derived from plants (e.g., antioxidants, echinacea, fenugreek, 
etc.), from animals and microorganisms (e.g. elk velvet, essential fatty acids, 
enzymes, etc.) and from marine sources (e.g., glucosamine, chitosan, fish oils, etc.).
What are functional foods and nutraceuticals?7
Firms involved in: Scientific Research and Development (R&D)





Who makes-up the Canadian FFN Industry?8Structure of the 
Canadian FFN Industry10
The majority of firms are small, but there are 
some large players in terms of both revenue and 
workforce size 
• Two-thirds of the  firms have only a small 
total workforce of less than 50 employees.
There are, however, a few large players with 4 
firms (3%) reporting a total workforce of more 
than 1000 employees.
• Firms in the Canadian FFN industry vary 
widely in terms of total revenue.
Thirty percent of the firms reported total 
earnings from all sources exceeding $10 million 
in 2002, another 40% reported earnings 
between $1 to$10 million and the remaining 
30% reported earnings of less than $1 million.
Chart 1
Distribution of FFN Firms by Total Revenue 
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Note: 1) Includes permanent, seasonal, casual and 
contract employees.11
FFN-related activities account for a large portion 
of total revenue and employment in some firms
• While there are a few firms (5%) that 
have more than 300 employees working 
directly with functional foods and 
nutraceuticals, most firms (55%) have 
less than 10 employees who spend time 
working in these areas.
• Twenty-six firms (17%) reported FFN-
related  revenues exceeding $10 million 
in 2002.
This implies that over one-half of the firms 
whose total revenue exceeds $10 million earn a 
substantial proportion of this revenue from 
functional foods and nutraceuticals.  
There are, however, a significant number of 
firms (24%) that earn less than $100,000 from 
FFN-related activities.
Chart 3



















Distribution of FFN Firms by Number of 
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2002
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Note: 1) Includes permanent, seasonal, casual and 
contract employees.12
The majority of firms are Canadian controlled 
private corporations that do not conduct R&D
• Individual firms engage in multiple 
activities throughout the value chain 
including scientific R&D, product 
development, ingredient manufacturing, 
product manufacturing, wholesaling, 
retailing and service provision.
Thirty-six percent of firms conduct R&D with 
respect to nutraceuticals and 34% conduct R&D 
with respect to functional foods. 
Chart 5
















• Eighty-five percent of the firms 
operating in the Canadian FFN industry 
are Canadian controlled and the 
remaining 15% foreign controlled. 
Roughly three-quarters of the firms are private 
corporations and another 10% are publically
traded corporations.  
Eleven percent of the firms are part of 
multinationals.
Chart 6
Percentage of FFN Firms by Value Chain 
Activity, 2002
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Note: 1) Service provision includes the provision of equipment, 
software and clinical testing.
• In 2002 only 5 firms (3%) allocated more 
than $1 million of their R&D budget to 
FFN-related areas.
The relatively large percentage of firms that do 
not conduct FFN-related R&D explains in part 
the response that 64% of firms allocated less 
than $100,000 to FFN-related R&D.  
Further analysis is needed to determine if the 
firms that do not conduct R&D are mostly 
wholesalers.
Chart 7
Distribution of FFN Firms by FFN-Related 





















• Plant-based nutraceuticals are the most 
common types of nutraceuticals with 
which firms deal. 
Plant-based nutraceuticals include those that are 
purified from plants, such as beta-glucan from 
oats and antioxidants from blueberries, and 
those that are ground from dried plant 
materials, such as echinacea and ginseng.
• The most common type of functional 
foods that firms deal with are those 
produced by adding active ingredients, 
such as soluble fibres and beta-glucan, to 
basic food products.
A smaller number of firms (21 firms) deal with 
functional foods developed via special 
production techniques. 
Plant-based nutraceuticals are the most common 
product types
• More firms work with nutraceuticals
than with  functional foods.
Chart 8
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Most firms have only a limited number of product 
lines
• Most of the product lines that firms 
offer on the market have ‘general well-
being’ as one of their focuses.
The immune system is the next most popular 
health aspect addressed by functional foods 
and nutraceuticals followed by heart disease 
and energy.
Product lines in development show a similar 
distribution with respect to health aspects 
targeted as those currently offered on the 
market.
• While there are some firms that offer 
more than 50 lines of FFN products, two-
thirds of the firms offer less than 10 
product lines. 
Further research is needed to determine 
whether wholesalers make-up a large 
proportion of the number of firms offering more 
than 50 product lines.
Chart 11
Distribution of FFN Firms by Number of 
Product Lines Offered, 2002
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Number of Product Lines by Disease State 
or Health Aspect Targeted, 2002
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Note: Firms were allowed to attribute individual product lines 
as targeting multiple disease states and health aspects.  
In addition, many of the same product lines may have 
been double counted by both manufacturers and 
wholesalers.15
‘General well being’ products are the largest 
revenue generators for most firms
• Products that focus on general well being, 
followed by those addressing heart health 
and the immune system tend to generate 
the most revenue for firms.
• Wholesaling is the distribution channel 
that is most widely used by firms, 
followed by third party distributors, such 
as brokers.
Around one-quarter of firms are selling through 
the Internet, and one-fifth through mail order.  
Chart 13
Distribution of FFN Firms by the Product 














































Percentage of FFN Firms by Source 























The most common FFN source ingredients are 
herbs and spices
• Around one-third of firms that use 
source ingredients base some of their 
FFN products on Canadian-grown herbs, 
oilseeds, and grains.
• Many firms import some of their source 
ingredients for FFN manufacturing.
Chart 16
Percentage of FFN Firms by Source 
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Note: These percentages apply only to the total number 
of firms that use FFN source ingredients. Data was 
not given on how many firms use FFN source 
ingredients.
Note: These percentages apply only to the total number 
of firms that use FFN source ingredients. Data was 
not given on how many firms use FFN source 
ingredients.17
Firms are only beginning to tap export markets
• Although nearly 60% of firms export 
some FFN products, most firms are 
primarily focused on the domestic 
market.  
Some firms have more than 30 product lines 
that are only available domestically.  Wholesalers 
may make-up the majority of these firms, but 
this needs to be determined with further 
research.   
Firms tend to have only a few product lines 
dedicated just to export sales.
• Most exporters (59 firms or 70%) earned 
less than $1 million from FFN export sales 
in 2002. 
Another 15 firms (18%) earned between $1-$5 
million.  Only 9 firms (11%) earned more than $5 
million in FFN export sales.
Chart 17
Percentage of FFN Firms by Number of 
FFN Product Lines Offered Only for 
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Note: These percentages apply only to the total number 
of firms that export FFN products.18
Most exports are focused on the US market
• Over three-quarters of exporters sell to 
the US and one-quarter to Japan.  The top 
European destinations are the UK, 
Germany and Italy.
Around 20% of the exporters are actively 
investigating expanding into the China market  
within the next 2 years. Other areas being 
looked into include Oceania and other Asian and 
European countries.
• Products are exported at each stage in 
the FFN production chain, from raw 
materials to finished products, even 
technology.
Chart 20





































Note: These percentages apply only to the total number 
of firms that export FFN products.
Note: These percentages apply only to the total number 
of firms that export FFN products.Labour and Capital Inputs
in the Canadian FFN Industry20
More marketing, research and production staff 
are needed
• The most common obstacle firms face in 
filling their FFN positions is lack of 
resources to attract qualified candidates.
One-third of the firms looking to hire FFN staff 
(12 firms) found that the job candidates that 
were available for work had insufficient expertise 
for their firm’s needs. 
• Approximately one-quarter of firms have 
unfilled FFN-related positions.  The 
majority of these firms are looking to fill 
marketing positions (23 firms), followed 
by scientific research positions (15 firms) 
and production positions (15 firms).
Only 4% of firms hired any FFN-related staff from 
outside Canada in 2002.
Chart 21
Percentage of FFN Firms with Unfilled 
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Note: These percentages apply only to the total number of 
firms  with unfilled FFN positions.
Note: These percentages apply only to the total number of 
firms  with unfilled FFN positions.21
Firms are seeking funding to expand all facets of 
their FFN operations
• Forty-six firms (32%) attempted to raise 
capital specifically for FFN-related 
purposes in 2002.
These firms were seeking funding to expand all 
facets of their operations from the R&D lab, to 
production capacity, and sales.
Only two-thirds of the firms that attempted to 
raise capital were successful and less than half 
reached their targeted funding level. 
Chart 23
Distribution of Firms Attempting to 























• Of these, about  one-half attempted to 
raise their FFN-related funding from 
conventional sources such as banks and 
IPO stock issues.
Other main sources for funding were Canadian-
based venture capital firms, government and 
angel investors including family and friends.  
Very few firms (3 firms) used American and other 
foreign venture capital.
The amount of FFN-related capital raised by 
individual firms varied. Seven firms were able to 
obtain over $1 million. Another 13 firms were 
able to obtain between $100,000 and $1 
million, and the remaining 10 firms less than 
$100,000.
Chart 24
Percentage of Firms that Raised 
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Note: These percentages apply only to the total number of 
firms  that raised some capital.22
Funding is more difficult to obtain in the early 
stages of product development
• Twenty-seven firms (59%) that 
attempted to raise FFN-related capital 
had some of their requests in 2002 
denied.
Reasons for these denials varied widely - the 
most common being capital unavailable due to 
market conditions and failure to meet lending 
criteria.  
A significant number of firms (14 firms),  
however, were turned down because of 
insufficient proof of concept and product 
development.  This may imply that funding 
may be more difficult to obtain in the early 
stages of FFN product development.
Chart 25
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Note: These percentages apply only to the total number of 
firms  that were denied a request for capital.Business Relationships and 
Intellectual Property Rights 
in the Canadian FFN Industry24
Many partnerships are conducting R&D
• Most partnership arrangements (69%) 
are made with other Canadian-based 
companies and organizations.
• Seventy-three percent of the firms that 
are in partnership arrangements 
conduct some of their scientific R&D 
through these arrangements. 
Firms also use their partnerships to arrange for 
the manufacture of FFN products (32 firms) 
and to gain access to distribution channels (32 
firms).
• Over one-third of firms are involved in 
partnership arrangements with other 
companies and organizations and one -
half are seeking to form new partnership 
arrangements.
Chart 26
Percentage of FFN Firms by their 
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Note: These percentages apply only to the total number of 
firms  in partnership arrangements.
Note: These percentages apply only to the total number of 
firms  in partnership arrangements.25
Contracts are used predominantly to fill 
production requirements
• Firms tend to retain exclusive control over 
their FFN-related intellectual property 
rights. 
In 2002 only 10 firms (7%) granted licensing 
agreements to other firms and only 25 firms 
(17%) obtained intellectual property rights from 
other firms. 
• Fifty-seven firms (39%) contracted out 
FFN-related activities in 2002.
Most of the contracts were related to the 
manufacture of products (40 firms) and the 
conducting of scientific R&D (29 firms). 
Chart 29
Percentage of Firms that Contracted Out 






















Percentage of FFN Firms by Intellectual 
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Note: These percentages apply only to the total number of 
firms  that contracted out FFN-related activities.26
Firms tend to use less formal means of 
intellectual property right protection such as 
trade secrets
• Trade secrets followed by registered 
trademarks are the most commonly used 
methods for protecting intellectual 
property rights.
Only 24 firms (17%) use patents.
• Over one-half of  the patents that firms 
now have are registered with the 
European Patent Office.
Pending patents on the other hand, are more or 
less equally distributed across patent offices 
around the world. 
Chart 31
Percentage of FFN Firms by Method of 
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Pending Patents Existing PatentsImpact of Regulations
in the Canadian FFN Industry28
Firms feel health claims could increase their sales
• In general, most firms feel that the ability 
to use health claims on their FFN products 
would have a positive impact on both 
their domestic and export sales.    
Although there was no significant difference in 
the total positive response between the ability to 
use generic health claims versus specific disease 
risk reduction claims and structure and function 
specific health claims, firms were the most 
strongly positive about disease risk reduction 
claims. 
• Over 60% of the firms feel that the ability 
to use any type of health claims would 
increase their willingness to conduct 
research to support these claims.
But firms think that the ability to use disease risk 
reduction claims would provide them with the 
greatest  overall incentive. 
Chart 33
Percentage of FFN Firms That Felt that 
the Ability to Use Health Claims would 
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Chart 34  
Percentage of FFN Firms That Felt that 
the Ability to Use Health Claims would 
have a Positive Impact on their 
Willingness to Conduct Research to 





















Firms are mixed on what would be the impact of 
matching US standards
• Just over half the firms thought that 
changing compositional and labeling 
regulations to match US standards 
would have a positive impact on their 
domestic and export sales. 
Roughly another 10% of the firms thought it 
would have a negative impact on domestic 
sales and 5% thought it would also hurt export 
sales.
The remaining firms were uncertain of  the 
impact on their domestic sales (21 firms) and 
export sales (27 firms) or considered it to be 
null (25 firms).
Chart 35
Percentage of FFN Firms According to 
their Perception of the Impact of 
Matching US Standard, 2002
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